📰 Insightsnet Present Value Model News
Insightsnet Present Value Model News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Insightsnet Present Value Model. Real-time updates on events, politics, business and more.
December 5, 2023
Dalzanemdor is a small molecule commercialized by Sage Therapeutics, with a leading Phase III program in Huntington Disease.
November 5, 2023
Dalzanemdor is a small molecule commercialized by Sage Therapeutics, with a leading Phase III program in Huntington Disease.
November 5, 2023
Laronidase is a recombinant enzyme commercialized by JCR Pharmaceuticals, with a leading Phase II program in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).
November 5, 2023
Barzolvolimab is a monoclonal antibody commercialized by Celldex Therapeutics, with a leading Phase II program in Eosinophilic Esophagitis.
August 28, 2023
Linavonkibart is a monoclonal antibody commercialized by Scholar Rock Holding, with a leading Phase I program in Non-Small Cell Lung Cancer.